In BC, ILC3s show a pro-tumorigenic behavior and were found to be increased in the TME [144]; indeed, in vitro studies show that ILC3s interact with stromal cells, favoring the expression of RANKL on them and in turn their interaction with RANK is expressed by a breast cancer cell line. The gene discussed is TNFRSF11A; the disease is breast cancer.